Login / Signup

Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.

George GrunbergerSarah CampJeremy JohnsonSusan HuyckSteven G TerraJames P MancusoZhi Wei JiangGregory GolmSamuel S EngelBrett Lauring
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
Clinicaltrials.gov identifier NCT01986855.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • glycemic control
  • cardiovascular risk factors
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle
  • weight loss